1. Home
  2. PTCT vs PBMWW Comparison

PTCT vs PBMWW Comparison

Compare PTCT & PBMWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • PBMWW
  • Stock Information
  • Founded
  • PTCT 1998
  • PBMWW N/A
  • Country
  • PTCT United States
  • PBMWW Canada
  • Employees
  • PTCT N/A
  • PBMWW 10
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • PBMWW
  • Sector
  • PTCT Health Care
  • PBMWW
  • Exchange
  • PTCT Nasdaq
  • PBMWW Nasdaq
  • Market Cap
  • PTCT N/A
  • PBMWW N/A
  • IPO Year
  • PTCT 2013
  • PBMWW N/A
  • Fundamental
  • Price
  • PTCT $45.08
  • PBMWW $0.02
  • Analyst Decision
  • PTCT Hold
  • PBMWW
  • Analyst Count
  • PTCT 13
  • PBMWW 0
  • Target Price
  • PTCT $52.77
  • PBMWW N/A
  • AVG Volume (30 Days)
  • PTCT 566.9K
  • PBMWW N/A
  • Earning Date
  • PTCT 02-27-2025
  • PBMWW N/A
  • Dividend Yield
  • PTCT N/A
  • PBMWW N/A
  • EPS Growth
  • PTCT N/A
  • PBMWW N/A
  • EPS
  • PTCT N/A
  • PBMWW N/A
  • Revenue
  • PTCT $900,664,000.00
  • PBMWW N/A
  • Revenue This Year
  • PTCT N/A
  • PBMWW N/A
  • Revenue Next Year
  • PTCT $14.26
  • PBMWW N/A
  • P/E Ratio
  • PTCT N/A
  • PBMWW N/A
  • Revenue Growth
  • PTCT 12.84
  • PBMWW N/A
  • 52 Week Low
  • PTCT $23.58
  • PBMWW N/A
  • 52 Week High
  • PTCT $54.16
  • PBMWW N/A
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 51.19
  • PBMWW N/A
  • Support Level
  • PTCT $41.75
  • PBMWW N/A
  • Resistance Level
  • PTCT $45.59
  • PBMWW N/A
  • Average True Range (ATR)
  • PTCT 1.96
  • PBMWW 0.00
  • MACD
  • PTCT -0.04
  • PBMWW 0.00
  • Stochastic Oscillator
  • PTCT 63.30
  • PBMWW 0.00

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: